Dr. Harlan F. Weisman
Challenging the status quo requires that leaders have the courage to take risks and the stamina to overcome resistance when conventional thinking is threatened by new ideas because this willingness to take the organization in a new direction is often the key to successful and continuous innovation.Harlan F. Weisman, MD
Dr. Harlan F. Weisman has over 20 years experience as a senior healthcare executive and physician responsible for the discovery, development, regulatory approval and launch of innovative pharmaceutical, biopharmaceutical, medical device and diagnostic products. He is the founder and Managing Director of And-One Consulting, LLC, advising medical product companies, investment firms, and government and non-government healthcare organizations in formulating and implementing successful strategies for driving innovation in healthcare products and services.
Previously, Dr. Weisman served as Chairman and CEO of Coronado Biosciences, Inc., a biopharmaceutical company engaged in the development of novel immunotherapy biologic agents for autoimmune diseases and cancer. Prior to Coronado, he served over 20 years as a senior executive at Johnson & Johnson. As the Chief Science and Technology Officer of the J&J Medical Devices and Diagnostics (MD&D) Group from 2006 -2012, Dr. Weisman steered the MD&D scientific and technical strategy including investments in Group-level technologies.
He also served as Chairman of the J&J Worldwide R&D Council. Preceding these roles, he was Company Group Chairman, J&J Pharmaceutical Research & Development, where he had executive oversight of the ALZA Corporation, Johnson & Johnson Pharmaceutical Research & Development (J&JPRD), and TransForm Pharmaceuticals, Inc.
Dr. Weisman's previous positions at J&J included President of J&JPRD and President of Centocor R&D, another member of the J&J family of companies. Before joining industry, Dr. Weisman was Assistant Professor of Medicine at Johns Hopkins University School of Medicine and Consultant Cardiologist at Johns Hopkins Hospital. Dr. Weisman received a B.A. from the University of Maryland and his M.D. from the University of Maryland School of Medicine. He did his residency in Internal Medicine at Mount Sinai Hospital in New York and a post-graduate fellowship in cardiovascular disease at Johns Hopkins Medical Institutions.
Dr. Weisman is currently on the Board of Governors of the Patient-Centered Outcomes Research Institute (PCORI), the Board of Directors of ControlRad Systems, and also serves on advisory committees to the Johns Hopkins University Institute for Basic Biomedical Sciences, and BioMotiv, a medical product accelerator company. Dr. Weisman has authored more than 100 articles and book chapters about cardiovascular disease, medical product development, healthcare policy and organizational development. He is a frequent invited speaker at international meetings on medical innovation, health policy and product development strategy.